Genetic trigger distribution in Angelman syndrome with their medical classification by the DNA methylation standing: Courses I–III typicallyshow irregular DNA methylation, whereas Class IV and V current regular methylation patterns. Credit score: Biomolecules and Biomedicine (2025). DOI: 10.17305/bb.2025.11724
A brand new overview sheds mild on the advanced molecular mechanisms behind Angelman syndrome (AS), a uncommon neurogenetic dysfunction, and explores how cutting-edge gene-targeting therapies could supply more practical therapy choices sooner or later.
The overview, printed in Biomolecules and Biomedicine, emphasizes the significance of understanding the genetic and epigenetic regulation of the UBE3A gene and its function in mind operate, with the objective of transferring past symptom administration towards disease-modifying interventions.
Angelman syndrome impacts an estimated 15,000 to 500,000 individuals worldwide. It’s characterised by extreme developmental delays, lack of speech, motor coordination issues, epilepsy, and a behavioral profile marked by frequent laughter, hyperactivity, and a typically blissful demeanor.
Whereas improvement seems typical within the first few months of life, indicators reminiscent of delayed milestones and seizures typically emerge by the tip of the primary 12 months. Nevertheless, prognosis is often delayed on account of overlapping options with different neurodevelopmental issues.
The basis explanation for AS is the lack of useful UBE3A gene expression in neurons. Not like most genes, that are expressed from each maternal and paternal copies, UBE3A is barely lively from the maternal allele in mind cells.
The paternal copy is silenced by a protracted noncoding RNA known as SNHG14 via a mechanism often known as “transcriptional collision”—the place overlapping transcription bodily interferes with gene expression. When the maternal gene is deleted or mutated, the paternal copy stays silenced, leading to an entire lack of UBE3A exercise within the mind.
Of their overview, researchers Jacqueline Fátima Martins de Almeida, Ilaria Tonazzini, and Simona Daniele element 5 molecular subtypes of Angelman syndrome, labeled based mostly on the precise genetic trigger. These embody massive deletions on chromosome 15 (the commonest kind), paternal uniparental disomy, imprinting defects, level mutations in UBE3A, and circumstances with unknown origins. This classification is just not solely related for prognosis however may affect therapy selections, as completely different subtypes could reply in a different way to rising therapies.
The authors spotlight promising advances in gene-targeting methods aimed toward reactivating the silent paternal UBE3A copy. Amongst these, antisense oligonucleotides (ASOs) have proven potential in preclinical research. By selectively focusing on SNHG14, ASOs can cut back the silencing transcript and permit the paternal gene to be expressed.
Animal research have demonstrated partial restoration of UBE3A exercise, and two early-phase medical trials (GeneTx NCT04259281 and Roche NCT04428281) are at present evaluating the security and efficacy of this method in people. Different strategies, reminiscent of topoisomerase inhibitors, have proven some effectiveness in reactivating UBE3A, however lack specificity and carry the next threat of off-target results.
Past gene reactivation, the overview underscores the significance of addressing the broader mobile dysfunction attributable to UBE3A loss. The UBE3A protein features as an E3 ubiquitin ligase, which helps regulate protein degradation, signaling, and synaptic operate within the mind. Its absence impacts a number of pathways, together with dopamine synthesis, circadian rhythm regulation, and synaptic plasticity—all of that are essential for studying and reminiscence.
A number of disrupted pathways are additionally mentioned intimately. For instance, decreased activation of the MAPK/ERK pathway has been linked to impaired reminiscence formation in AS mouse fashions, whereas upregulation of the JNK stress pathway could contribute to neurodegeneration.
Irregular calcium signaling and elevated adenosine A2A receptor exercise within the hippocampus additional contribute to synaptic dysfunction. Notably, pharmacological inhibition of the A2A receptor has proven therapeutic results in preclinical research.
The authors counsel {that a} mixture remedy method—focusing on each gene expression and downstream pathways—could also be the simplest technique for treating AS. This twin focus might supply extra strong and lasting enhancements in cognitive, behavioral, and motor operate than gene remedy alone. In addition they advocate tailoring therapy methods based mostly on molecular subtype, as completely different genetic causes could require completely different therapeutic interventions.
Whereas challenges stay—together with the necessity for exact gene-targeting instruments, higher supply methods, and long-term security knowledge—the overview paints a hopeful image of future therapy potentialities. As gene-based therapies transfer from the lab to medical trials, researchers and clinicians are optimistic that these approaches might ultimately result in transformative outcomes for people with Angelman syndrome.
The research affords a complete overview of present understanding and therapeutic progress, signaling a shift from managing signs to addressing the foundation molecular causes of this advanced dysfunction.
Extra info:
Jacqueline Fátima Martins de Almeida et al, Molecular elements of Angelman Syndrome: Defining the brand new path ahead, Biomolecules and Biomedicine (2025). DOI: 10.17305/bb.2025.11724
Supplied by
Affiliation of Fundamental Medical Sciences of FBIH
Quotation:
Molecular methods for Angelman syndrome explored in research (2025, June 3)
retrieved 3 June 2025
from https://medicalxpress.com/information/2025-06-molecular-strategies-angelman-syndrome-explored.html
This doc is topic to copyright. Other than any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.
